| Literature DB >> 3964531 |
T Pringle, J Fox, J A McNeill, C D Kinney, J Liddle, D W Harron, R G Shanks.
Abstract
In 12 healthy volunteers who received orally 100, 200, 300, 400 and 600 mg mexiletine at weekly intervals, the maximum plasma concentration of mexiletine and AUC increased linearly with the dose of mexiletine. Between doses there were no significant differences in the values for clearance and volume of distribution of mexiletine but there were for plasma elimination half-life. These results indicate that the kinetics of mexiletine are linear.Entities:
Mesh:
Substances:
Year: 1986 PMID: 3964531 PMCID: PMC1400855 DOI: 10.1111/j.1365-2125.1986.tb05196.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335